Ablynx

@AblynxABLX

Ablynx is a biopharmaceutical company engaged in the discovery and development of Nanobodies® for a range of serious human diseases.

Ghent/Zwijnaarde, Belgium
ablynx.com
Participa desde maio de 2012
5 Fotos e vídeos Fotos e vídeos

Tweets

Você bloqueou @AblynxABLX

Tem certeza de que deseja ver estes Tweets? Visualizar os Tweets não desbloqueará @AblynxABLX

  1. retweetou
    26 de jul

    FDA designates top nanobody caplacizumab fast track designation: 6-10 months faster approval

    3 retweets 4 curtiram
  2. retweetou
    20 de jul

    2.4bn "bioeuro": Belgian Nanobody delights now also tasteful in France

    2 retweets 7 curtiram
  3. 20 de jul

    and Sanofi to develop up to 8 Nanobody®-based therapeutics focused on immuno-inflammatory diseases

    1 resposta 9 retweets 14 curtiram
  4. 27 de jun

    achieves second milestone in immuno-oncology collaboration with Merck & Co., Inc.

    7 retweets 16 curtiram
  5. 26 de jun

    initiates a single and multiple dose Phase I study of caplacizumab in healthy Japanese subjects

    4 retweets 6 curtiram
  6. 29 de mai

    launches , a new website dedicated to Thrombotic Thrombocytopenic Purpura (TTP)

    10 retweets 9 curtiram
  7. 22 de mai

    receives €15M milestone from Merck KGaA for novel Nanobody in osteoarthritis

    10 retweets 12 curtiram
  8. 18 de mai

    Meet our experts and recruiters (booth 99) @

    2 curtiram
  9. 11 de mai

    Ablynx zit op schema via

    4 retweets 6 curtiram
  10. 11 de mai

    Q1 2017 "Positive start of the year; good progress in multiple programmes; strong cash position"

    6 retweets 4 curtiram
  11. 10 de mai

    Publication in Journal of Thrombosis and Haemostasis "Caplacizumab reduces major thromboembolic events"

    7 retweets 7 curtiram
  12. 2 de mai

    successfully completes patient recruitment in its Phase III Hercules study of caplacizumab

    2 retweets 6 curtiram
  13. 7 de abr

    Annual Report 2016 is available online - view via

    1 retweet 4 curtiram
  14. 7 de abr

    - Adrianus van Herk (aandeelhouder Ablynx): 'België en Nederland zijn wereldtop' via @trends

    1 retweet 4 curtiram
  15. retweetou
    6 de mar

    Compelling data for developed psoriasis nanobody in collaboration

    3 retweets 2 curtiram
  16. retweetou
    28 de fev

    Good morning to those waking up in Europe, Africa and the Middle East! Share with us what you have planned for today!

    15 respostas 51 retweets 103 curtiram
  17. retweetou
    24 de fev

    you will find out that is dedicated to creating new medicines which will make a real difference to society!

    1 retweet 1 curtiu
  18. 23 de fev

    FYR 2016: significant progress in R&D pipeline; strong cash position; major catalysts in 2017.

    4 retweets 3 curtiram
  19. 9 de fev

    will present additional data from the Phase IIb RA combination study of vobarilizumab at the Annual CRA Meeting

    2 retweets 2 curtiram
  20. 6 de fev

    Ablynx files caplacizumab for ultra rare blood disorder
    6 retweets 9 curtiram

@AblynxABLX ainda não tweetou.

O carregamento parece estar demorando.

O Twitter deve estar sobrecarregado ou passando por algum problema momentâneo. Tente novamente ou acesse o Status do Twitterpara obter mais informações.

    Você também pode gostar

    ·